Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gemma Modinos

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 4, 2018
Correction: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 28, 2024
Towards a consensus roadmap for a new diagnostic framework for mental disordersMartien J H Kas, Steven Hyman, Leanne M Williams, et al.
Frontiers in Psychiatry|May 29, 2019
Basic Self-Disturbances Related to Reduced Anterior Cingulate Volume in Subjects at Ultra-High Risk for PsychosisIlaria Bonoldi, Paul Allen, Luis Madeira, et al.
Biological Psychiatry|February 9, 2025
Transcriptional and Neurochemical Signatures of Cerebral Blood Flow Alterations in Individuals With Schizophrenia or at Clinical High Risk for PsychosisSamuel R Knight, Leyla Abbasova, Yashar Zeighami, et al.
Schizophrenia Bulletin|January 3, 2018
Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second CohortPaul Allen, Matilda Azis, Gemma Modinos, et al.
Schizophrenia Bulletin|December 27, 2022
Erbb4 Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging PhenotypesAmanda Kiemes, Maria Elisa Serrano Navacerrada, Eugene Kim, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2019
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosisCathy Davies, Yannis Paloyelis, Grazia Rutigliano, et al.
Schizophrenia Bulletin|April 1, 2020
Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical OutcomeGemma Modinos, Paul Allen, Andre Zugman, et al.
Human Brain Mapping|October 13, 2020
Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosisGeorge Gifford, Nicolas Crossley, Sarah Morgan, et al.
Schizophrenia Bulletin|February 22, 2020
Emotion Recognition and Adverse Childhood Experiences in Individuals at Clinical High Risk of PsychosisStefania Tognin, Ana Catalan, Gemma Modinos, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 4, 2018
Correction: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 28, 2024
Towards a consensus roadmap for a new diagnostic framework for mental disordersMartien J H Kas, Steven Hyman, Leanne M Williams, et al.
Frontiers in Psychiatry|May 29, 2019
Basic Self-Disturbances Related to Reduced Anterior Cingulate Volume in Subjects at Ultra-High Risk for PsychosisIlaria Bonoldi, Paul Allen, Luis Madeira, et al.
Biological Psychiatry|February 9, 2025
Transcriptional and Neurochemical Signatures of Cerebral Blood Flow Alterations in Individuals With Schizophrenia or at Clinical High Risk for PsychosisSamuel R Knight, Leyla Abbasova, Yashar Zeighami, et al.
Schizophrenia Bulletin|January 3, 2018
Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second CohortPaul Allen, Matilda Azis, Gemma Modinos, et al.
Schizophrenia Bulletin|December 27, 2022
Erbb4 Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging PhenotypesAmanda Kiemes, Maria Elisa Serrano Navacerrada, Eugene Kim, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2019
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosisCathy Davies, Yannis Paloyelis, Grazia Rutigliano, et al.
Schizophrenia Bulletin|April 1, 2020
Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical OutcomeGemma Modinos, Paul Allen, Andre Zugman, et al.
Human Brain Mapping|October 13, 2020
Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosisGeorge Gifford, Nicolas Crossley, Sarah Morgan, et al.
Schizophrenia Bulletin|February 22, 2020
Emotion Recognition and Adverse Childhood Experiences in Individuals at Clinical High Risk of PsychosisStefania Tognin, Ana Catalan, Gemma Modinos, et al.
Pageof 9